The journal of medical investigation : JMI · 2026
Congenital Factor XI deficiency in an elderly Japanese male accompanied by nonsense mutation p.Trp519* and novel missense mutation p.Ile618Phe.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sugasaki Motoki, Nakamura Shingen, Nakagawa Hiromi, Teramoto Keisuke, Urushihara Minami, Inoue Yusuke, Nakao Takayuki, Sata Masataka, Matsuoka Ken-Ichi
Аннотация
OBJECTIVE: In the present study, we identified a genetic mutation in a patient with asymptomatic congenital Factor XI (FXI) deficiency, with an FXI activity of <1%. The mutation was accidentally discovered when the patient was 80 years old.
METHODS: We performed genome sequencing (GS) on using a whole blood sample from the patient. The nucleotide sequences obtained were compared to the FXI reference GS and mutations were assessed using BioEdit.
RESULTS: Notably, exon 14 was not amplified;therefore, all other exons were analyzed. Four heterozygous nucleotide mutations were noted:c.1556G>A, c.1812G>T, c.1839G>A, and c.1852A>T;c.1556G>A and c.1852A>T were associated with amino acid substitutions p.Trp519* and p. Ile618Phe, respectively. Some cases of the amino acid substitution p.Trp519* have been registered in the database;however, to the best of our knowledge, p.Ile618Phe was likely discovered for the first time in this study.
CONCLUSION: Because both gene mutations were heterozygous, the patient had compound heterozygous mutations that decreased FXI activity. J. Med. Invest. 73 : 281-285, February, 2026.
METHODS: We performed genome sequencing (GS) on using a whole blood sample from the patient. The nucleotide sequences obtained were compared to the FXI reference GS and mutations were assessed using BioEdit.
RESULTS: Notably, exon 14 was not amplified;therefore, all other exons were analyzed. Four heterozygous nucleotide mutations were noted:c.1556G>A, c.1812G>T, c.1839G>A, and c.1852A>T;c.1556G>A and c.1852A>T were associated with amino acid substitutions p.Trp519* and p. Ile618Phe, respectively. Some cases of the amino acid substitution p.Trp519* have been registered in the database;however, to the best of our knowledge, p.Ile618Phe was likely discovered for the first time in this study.
CONCLUSION: Because both gene mutations were heterozygous, the patient had compound heterozygous mutations that decreased FXI activity. J. Med. Invest. 73 : 281-285, February, 2026.